UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

Endowment

Position in LLY — ELI LILLY & Co

CIK 1019231 AUSTIN, TX

Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$1,336,165

+$926,868 QoQ

Shares Held

1,114

+150.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#2,861

of 4,605 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO holds $7,291,310 across 9 Drug Manufacturers - General names. LLY ranks #2 (18.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	165,020	$3,973,681
2	LLY	ELI LILLY & Co This page	1,114	$1,336,165
3	NVS	Novartis AG	4,919	$770,905
4	JNJ	Johnson & Johnson	1,678	$426,161
5	ABBV	AbbVie Inc.	1,204	$302,974
6	MRK	Merck & Co., Inc.	1,783	$229,115
7	GILD	Gilead Sciences, Inc.	950	$120,023
8	BMY	Bristol Myers Squibb Co	1,460	$84,125

All Filings in LLY

Export CSV

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,336,165	1,114	+150.3%	Shares	Sole	2026-08-03
2026-03-31	$409,297	445	+8.8%	Shares	Sole	2026-05-07
2025-12-31	$439,544	409	-93.5%	Shares	Sole	2026-02-17
2025-09-30	$4,796,981	6,287	-9.1%	Shares	Sole	2025-11-13
2025-06-30	$5,391,229	6,916	-1.3%	Shares	Sole	2025-07-31
2025-03-31	$5,787,151	7,007	-16.2%	Shares	Sole	2025-05-07
2024-12-31	$6,451,604	8,357	-17.3%	Shares	Sole	2025-02-19
2024-09-30	$8,955,081	10,108	+52.9%	Shares	Sole	2024-11-13
2024-06-30	$5,984,561	6,610	-0.3%	Shares	Sole	2024-09-17
2024-03-31	$5,156,318	6,628	+2540.6%	Shares	Sole	2024-08-29
2023-12-31	$146,312	251	+20.1%	Shares	Sole	2024-08-29
2023-09-30	$112,260	209	—	Shares	Sole	2024-08-29
No filing history on record for this holder in this stock.